Digital start-up Reflexion Health has raised $18m in funding, which it says will be used to "complete clinico-economic evaluation" of VERA, its first FDA-approved telerehabilitation system. The company is also working with the US Food and Drug Administration (FDA) to develop a clinical trial for patients who have been diagnosed with vertigo but are unable or unwilling to undergo traditional medical treatment. Reflexion Health says VERA is designed for health care systems that have adopted a "value-based care model" and can offer "more control" to care delivery in a "post-acute setting". The company is in talks to broaden VERA's remit to include patients recovering from joint surgery.
Digital start-up Reflexion Health has raised $18m in funding, which it says will be used to "complete clinico-economic evaluation" of VERA, its first FDA-approved telerehabilitation system. The platform offers a suite of prescription exercises, a 3D imaging system to assess progress and monitor movement, and can offer an off-line clinical review. Reflexion Health says VERA is designed for health care systems that have adopted a "value-based care model" and can offer "more control" to care delivery in a "post-acute setting". The company is in talks to broaden VERA's remit to include patients recovering from joint surgery.